Psychedelics Mescaline drug developer Neural Therapeutics closes funding needed for CSE listing This company's primary focus is making an extract from San Pedro -- a psychedelic cactus Rowan DunneMarch 14, 2025
Psychedelics Psilocybin shows great promise for brain recovery after head injuries in rodents These findings are reinforced by the growing popularity of psychedelics among athletes who have had multiple concussions Rowan DunneMarch 6, 2025
Psychedelics Colorado students interested in psychedelics gain access to US$1.5M grant Those enrolling at Naropa University who want to do a minor in psychedelics now have more incentive Rowan DunneMarch 4, 2025
Psychedelics Synthetic ibogaine: a game changer for mental health treatment Scientists at UC Davis are making a short supply of the African iboga shrub a less significant problem Rowan DunneFebruary 13, 2025
Psychedelics 51 Colorado residents become state’s first certified magic mushroom therapists They recently graduated from a psychedelic therapy facilitator program run by InnerTrek Rowan DunneFebruary 12, 2025
Psychedelics ‘Snowball Cubensis’ psilocybin strain turns heads, completely unique The world has never seen anything quite like this Rowan DunneFebruary 7, 2025
Psychedelics Tacoma joins Seattle in making psychedelics law enforcement lowest priority The resolution passed on Jan. 28 also aims to push for statewide decriminalization Rowan DunneFebruary 6, 2025
Psychedelics GH Research skyrockets on 5-MeO-DMT drug’s depression treatment breakthrough Shares surged by nearly 125% during pre-market hours Rowan DunneFebruary 3, 2025
Psychedelics Optimi Health produces largest-ever batch of MDMA capsules The MDMA, psilocybin and functional mushroom producer also just scooped more funding Rowan DunneJanuary 29, 2025
Psychedelics Edmonton’s new psychedelic therapy clinic helps residents soothe the winter blues It offers ketamine, psilocybin, and MDMA therapy sessions Rowan DunneJanuary 27, 2025